COX-2 expression in gastric cancer and its relationship with angiogenesis using tissue microarray

World Journal of Gastroenterology

Volumn 13, Issue 25, 2007, Pages 3466-3471

  Mao, Xiao Yun ^a   Wang, Xiao Ge ^a   Lv, Xiao Jun ^b   Xu, Lei ^a   Han, Cheng Bo ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b LIAONING CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

CD34; COX 2; Gastric cancer; Immunohistochemistry; Microvessel density; Tissue microarray

Indexed keywords

CD34 ANTIGEN; CYCLOOXYGENASE 2;

ARTICLE; CANCER CLASSIFICATION; CANCER GENETICS; CANCER INVASION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MICROVASCULATURE; PROGNOSIS; PROTEIN EXPRESSION; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH SURGERY; TISSUE MICROARRAY; TUMOR VASCULARIZATION;

EID: 34547421890     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i25.3466     Document Type: Article

References (28)

1. Han CB, Mao XY, Xin Y, Wang SC, Ma JM, Zhao YJ. Quantitative analysis of tumor mitochondrial RNA using microarray. World J Gastroenterol 2005; 11: 36-40
2. Zheng M, Simon R, Kononen J, Sauter G, Mihatsch MJ, Moch H. Analysis of gene expression profiles among 3 epithelial ovarian tumor subtypes using cDNA and tissue microarrays. Ai Zheng 2004; 23: 771-776
3. Andersen CL, Monni O, Wagner U, Kononen J, Barlund M, Bucher C, Haas P, Nocito A, Bissig H, Sauter G, Kallioniemi A. High-throughput copy number analysis of 17q23 in 3520 tissue specimens by fluorescence in situ hybridization to tissue microarrays. Am J Pathol 2002; 161: 73-79
4. Gamradt SC, Feeley BT, Liu NQ Roostaeian J, Lin YQ, Zhu LX, Sharma S, Dubinett SM, Lieberman JR. The effect of cyclooxygenase-2 (COX-2) inhibition on human prostate cancer induced osteoblastic and osteolytic lesions in bone. Anticancer Res 2005; 25: 107-115
5. Hasegawa K, Ohashi Y, Ishikawa Y, Yasue A, Kato R, Achiwa Y, Nishic, E, Udagawa Y. Expression of cyclooxygenase-2 in uterine endometrial cancer and anti-tumor effects of a selective COX-2 inhibitor. Int J Oncol 2005; 26: 1419-1428
6. Block KI. Inflammation, COX-2 inhibitors, and cancer. Integr Cancer Ther 2005; 4: 3-4
7. Wendum D, Masliah J, Trugnan G, Flejou JF. Cyclooxygenase-2 and its role in colorectal. cancer development. Virchows Arch 2004; 445: 327-333
8. Koehne CH, Dubois RN. COX-2 inhibition and colorectal cancer. Semin Oncol 2004; 31: 12-21
9. Hutchison R. COX-2--selective NSAIDs. Am I Nurs 2004; 104: 52-55; quiz 55-56
10. Evans JF, Kargman SL. Cancer and cyclooxygenase-2 (COX-2) inhibition. Curr Pharm Des 2004; 10: 627-634
11. Boxer GM, Tsiompanou E, Levine T, Watson R, Begent RH. Immunohistochemical expression of vascular endothelial growth factor and microvessel counting as prognostic indicators in node-negative colorectal cancer. Tumour Biol 2005; 26:1-8
12. Preziosi R, Sarli G, Paltrinieri M. Prognostic value of intratumoral vessel density in cutaneous mast cell tumors of the dog. J Comp Pathol 2004; 130: 143-151
13. Li H, Sun Y, Kong QY, Zhang KL, Wang XW, Chen XY, Wang Q, Liu J. Combination of nucleic acid and protein isolation with tissue array construction: using defined histologic regions in single frozen tissue blocks for multiple research purposes. Int J Mol Med 2003; 12: 299-304
14. Lusis EA, Chicoine MR, Perry A. High throughput screening of meningioma biomarkers using a tissue microarray. J Neurooncol 2005; 73: 219-223
15. Sun Y, Li JY, He JS, Zhou LX, Chen K. Tissue microarray analysis of multiple gene expression in intestinal metaplasia, dysplasia and carcinoma of the stomach. Histopathology 2005; 46:505-514
16. Moch H, Schraml P, Bubendorf L, Mirlacher M, Kononen J, Gasser T, Mihatsch MJ, Kallioniemi OP, Sauter G. High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. Am J Pathol 1999; 154: 981-986
17. Schraml P, Kononen J, Bubendorf L, Modi H, Bissig H, Nocito A, Mihatsch MJ, Kallioniemi OP, Sauter G. Tissue microarrays for gene amplification surveys in many different tumor types. Clin Cancer Res 1999; 5: 1966-1975
18. Mohammed NA, Abd El-Aleein SA, El-Hafiz HA, McMahon RF. Distribution of constitutive (COX-1) and inducible (COX-2) cyclooxygenase in postviral human liver cirrhosis: a possible role for COX-2 in the pathogenesis of liver cirrhosis. J Clin Pathol 2004; 57: 350-354
19. Singh B, Berry JA, Shoher A, Ramakrishnan V, Lucci A. COX-2 overexpression increases motility and invasion of breast cancer cells. Int J Oncol 2005; 26: 1393-1399
20. Eibl G, Takata Y, Boros LG, Liu J, Okada Y, Reber HA, Hines 0J. Growth stimulation of COX-2-negative pancreatic cancer by a selective COX-2 inhibitor. Cancer Res 2005; 65: 982-990
21. Yazawa K, Tsuno NH, Kitayama. J, Kawai K, Okaji Y, Asakage M, Sunami E, Kaisaki S, Hori N, Watanabe T, Takahashi K, Nagawa H. Selective inhibition of cyclooxygenase-2 inhibits colon cancer cell adhesion to extracellular matrix by decreased expression of betal integrin. Cancer Sci 2005; 96: 93-99
22. Murata H, Kawano S, Tsuji S, Tsuji M, Sawaoka H, Kimura Y, Shiozaki H, Hori M. Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma. Am J Gastroenterol 1999; 94:451-455
23. Fosslien E. Review: molecular pathology of cyclooxygenase-2 in cancer-induced angiogenesis. Ann Clin Lab Sci 2001; 31: 325-348
24. Ohno R, Yoshinaga K, Fujita. T, Hasegawa K, Iseki H, Tsunozaki H, Ichikawa W, Nihei Z, Sugihara K. Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma. Cancer 2001; 91: 1876-1881
25. Lim HY, Joo HJ, Choi JH, Yi JW, Yang MS, Cho DY, Kim HS, Nam DK, Lee KB, Kim HC. Increased expression of cyclooxygenase-2 protein in human, gastric carcinoma. Clin Cancer Res 2000; 6: 519-525
26. Arbiser JL. Implications of Epstein-Barr Virus (EBV)-induced carcinogenesis on cutaneous inflammation and carcinogenesis: evidence of recurring patterns of angiogenesis and signal transduction. J Invest Dermatol 2005; 124: xi-xii
27. Yoshiji H, Noguchi R, Kuriyama S, Yoshii J, Ikenaka Y. Combination of interferon and angiotensin-converting enzyme inhibitor, perindopril, suppresses liver carcinogenesis and angiogenesis in mice. Oncol Rep 2005; 13: 491-495
28. Onizuka S, Kawakami S, Taniguchi K, Fujioka H, Miyashita K. Pancreatic carcinogenesis: apoptosis and angiogenesis. Pancreas 2004; 28: 317-319